FDA — authorised 15 March 1966
- Application: ANDA060462
- Marketing authorisation holder: SCHERING
- Local brand name: GARAMYCIN
- Indication: CREAM — TOPICAL
- Status: approved
FDA authorised Garamycin on 15 March 1966
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 15 March 1966; FDA authorised it on 15 March 1966; FDA authorised it on 19 June 1970.
SCHERING holds the US marketing authorisation.